Page last updated: 2024-10-29

indomethacin and Cochlear Hearing Loss

indomethacin has been researched along with Cochlear Hearing Loss in 4 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research Excerpts

ExcerptRelevanceReference
"A 41-year-old man with pre-existing cardiac and renal dysfunction (for which his regular medications included furosemide) presumed secondary to a viral myocarditis developed acute sensorineural hearing loss 5 days after commencing treatment with indomethacin 25 mg tds for acute gout."3.76Irreversible sensorineural hearing loss: an unusual side effect of non-steroidal anti-inflammatory drugs. ( Ahmad, S; Bhanji, A; Karim, M; Pal, S, 2010)
"Out of a population of 92 patients with Bartter syndrome, five suffered from mild to severe hypoacusia and were selected for mutational screening."1.33Type IV Bartter syndrome: report of two new cases. ( Bettinelli, A; Emma, F; Marseglia, GL; Palma, A; Taranta, A; Zaffanello, M, 2006)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Gupta, P1
Anne, RP1
Deshabhotla, SK1
Nerakh, G1
Ahmad, S1
Bhanji, A1
Pal, S1
Karim, M1
Shalev, H1
Ohali, M1
Kachko, L1
Landau, D1
Zaffanello, M1
Taranta, A1
Palma, A1
Bettinelli, A1
Marseglia, GL1
Emma, F1

Other Studies

4 other studies available for indomethacin and Cochlear Hearing Loss

ArticleYear
Antenatal Indomethacin Use Altering the Initial Presentation of Type 4A Bartter Syndrome.
    Indian journal of pediatrics, 2021, Volume: 88, Issue:8

    Topics: Bartter Syndrome; Female; Hearing Loss, Sensorineural; Humans; Indomethacin; Pregnancy; Prenatal Dia

2021
Irreversible sensorineural hearing loss: an unusual side effect of non-steroidal anti-inflammatory drugs.
    International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:8

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Gout; Hearing Loss, Sensorineural; Hu

2010
The neonatal variant of Bartter syndrome and deafness: preservation of renal function.
    Pediatrics, 2003, Volume: 112, Issue:3 Pt 1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arabs; Chromosomes, Human, Pair 1; Dietary Supplements; Fem

2003
Type IV Bartter syndrome: report of two new cases.
    Pediatric nephrology (Berlin, Germany), 2006, Volume: 21, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Bartter Syndrome;

2006